Linked Life Data

15035261

Source:http://linkedlifedata.com/resource/pubmed/id/15035261

Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
4
pubmed:dateCreated
2004-3-22
pubmed:abstractText
After many years of debate, Congress recently approved a new, voluntary "Medicare Part D" benefit that provides some coverage for prescription drugs. The goal of this coverage is to reduce financial barriers that might prevent beneficiaries from obtaining needed drugs. The degree to which this goal is achieved depends on how well the benefit reaches seniors with previously unmet needs; conversely, it may do little to improve seniors' health if it replaces existing sources of coverage, or encourages overuse of drugs. This Issue Brief reviews data on current patterns of drug spending among Medicare beneficiaries and summarizes aspects of the new benefit. It explores the likely effect of the coverage on overall use of and spending for prescription drugs and considers whether any additional use is likely to represent needed care that had been forgone because of a cost barrier.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
T
pubmed:status
MEDLINE
pubmed:issn
1553-0671
pubmed:author
pubmed:issnType
Electronic
pubmed:volume
9
pubmed:owner
HSR
pubmed:authorsComplete
Y
pubmed:pagination
1-6
pubmed:dateRevised
2004-11-17
pubmed:meshHeading
pubmed:articleTitle
The new Medicare drug benefit: much ado about little?
pubmed:affiliation
The Wharton School, University of Pennsylvania, Philadelphia, PA, USA.
pubmed:publicationType
Journal Article